US 9518050
Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity
granted A61KA61K31/13A61K31/4184
Quick answer
US patent 9518050 (Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity) held by Almirall, S.A. expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61K, A61K31/13, A61K31/4184, A61K31/439, A61K31/4704